Latest news

  • ASCENT procurement announcement: Requests for quotation

    Monday 13 January

    The ASCENT project has two requests for quotation (RFQ’s): 1. For printing of cardstock medication sleeves. 2. To facilitate incoming and outgoing interactions with adherence platform. KNCV Tuberculosis Foundation KNCV […]

    Read more
  • Resistant forms of TB: more patient-friendly treatment

    Monday 13 January

    People suffering from resistant forms of tuberculosis (TB) can now be cured by more patient-friendly treatments. The World Health Organization (WHO) recommends the use of these new treatments under certain […]

    Read more
  • TB Stigma Reduction Symposium

    Sunday 12 January

    INVITATION: Stigma and discrimination are recognized as some of the most commonly identified barriers to fight the Tuberculosis (TB) epidemic. During the TB Stigma Reduction Symposium: “You have to know […]

    Read more
  • The story of Abdurahim

    Sunday 12 January

    Four-year-old Abdurahim from Kyrgyzstan is so small he looks half that age. He had spinal and intra-thoracic lymph node tuberculosis (TB), a very rare and dangerous form of the disease […]

    Read more
  • Start of a new era in fight against drug resistant TB

    Thursday 12 December

    WHO released a rapid communication on the treatment of drug resistant (DR) and extensively drug resistant (XDR) tuberculosis (TB). This puts an ‘end to tears’, for painful daily injections in […]

    Read more
  • 7th European Advanced Course in Clinical Tuberculosis

    Wednesday 20 November

    The 7th European Advanced Course in Clinical Tuberculosis (TB) offered an informative and interactive program with national and international speakers with a comprehensive experience in the field of clinical tuberculosis […]

    Read more
  • 3HP regimen soon to be accessible in Malawi

    Thursday 31 October

    KNCV Tuberculosis Foundation Malawi welcomes the substantial reduction in the price of the anti-tuberculosis drug rifapentine, announced today at the Union World Conference on Lung Health in India. “For people […]

    Read more
  • Important price reduction improves access to TB prevention

    Thursday 31 October

    KNCV Tuberculosis Foundation welcomes the announcement of a substantial reduction in the price of an anti-tuberculosis medicine through the support of Unitaid and the Global Fund, in partnership with the […]

    Read more
  • Innovative TB treatment support project kicks off in the Philippines

    Wednesday 25 September

    ASCENT aims to assist patients succeed in treatment using digital adherence technology. On World Lung Day, the innovative TB treatment support project ASCENT kicks off in the Philippines, making the […]

    Read more
  • Antacid helps tuberculosis bacteria to survive

    Sunday 1 September

    In 2017, some 10 million people suffered from tuberculosis and 1.6 million died of the disease. One reason why infection with Mycobacterium tuberculosis is so difficult to treat is that […]

    Read more
  • FDA approval of BPaL regimen an important breakthrough in TB control

    Wednesday 14 August

    The US Food & Drug Administration (FDA) today approved pretomanid for the treatment of highly drug-resistant forms of tuberculosis (TB) in a combination regimen known as BPaL. This regimen was […]

    Read more
  • ASCENT: Empowering patients through digital technology

    Tuesday 23 July

    GENEVA/THE HAGUE, The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands for Adherence Support Coalition to End TB. This brand new […]

    Read more